Home
>
National Drug Code (NDC)
>
Cathflo Activase
Cathflo Activase - 50242-041-64 - (Alteplase)
Drug Information of Cathflo Activase
| Product NDC: | 50242-041 |
| Proprietary Name: | Cathflo Activase |
| Non Proprietary Name: | Alteplase |
| Active Ingredient(s): | 2.2 mg/2mL & nbsp; Alteplase |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cathflo Activase
| Product NDC: | 50242-041 |
| Labeler Name: | Genentech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103172 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20010904 |
Package Information of Cathflo Activase
| Package NDC: | 50242-041-64 |
| Package Description: | 1 VIAL in 1 CARTON (50242-041-64) > 2 mL in 1 VIAL |
NDC Information of Cathflo Activase
| NDC Code | 50242-041-64 |
| Proprietary Name | Cathflo Activase |
| Package Description | 1 VIAL in 1 CARTON (50242-041-64) > 2 mL in 1 VIAL |
| Product NDC | 50242-041 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Alteplase |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20010904 |
| Marketing Category Name | BLA |
| Labeler Name | Genentech, Inc. |
| Substance Name | ALTEPLASE |
| Strength Number | 2.2 |
| Strength Unit | mg/2mL |
| Pharmaceutical Classes |
